中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

256 records (took 0.034 seconds)

    DETERMINATION OF CARDIAC CONDUCTION SYSTEM THERAPY BENEFIT
    43.
    发明公开
    DETERMINATION OF CARDIAC CONDUCTION SYSTEM THERAPY BENEFIT 审中-公开

    公开(公告)号：US20230172521A1

    公开(公告)日：2023-06-08

    申请号：US17969961

    申请日：2022-10-20

    Applicant: Medtronic, Inc.

    Inventor： Subham Ghosh

    IPC: A61B5/367 ,  A61B5/339 ,  A61B5/00 ,  A61B5/282

    CPC classification number: A61B5/367 ,  A61B5/339 ,  A61B5/7475 ,  A61B5/282

    Abstract: Determination of cardiac conduction system pacing therapy benefit may be performed by the systems, methods, devices, and interfaces described herein. For example, various metrics of activation time dispersion may be generated based on electrical activity monitored by a plurality of external electrodes such as, e.g., a left-sided metric of dispersion and a global metric of dispersion. Such various metrics of activation time dispersion may be used to determined whether cardiac conduction system pacing would be beneficial.

    Systems, methods, and devices for adaptive cardiac therapy
    45.
    发明授权
    Systems, methods, and devices for adaptive cardiac therapy 有权

    公开(公告)号：US11547858B2

    公开(公告)日：2023-01-10

    申请号：US16369948

    申请日：2019-03-29

    Applicant: Medtronic, Inc.

    Inventor： Subham Ghosh ,  Aleksandre Sambelashvili ,  Jeffrey Gillberg ,  Manfred Justen ,  Sean Farrell

    IPC: A61N1/368 ,  A61B5/282

    Abstract: Systems, methods, and devices are described herein for evaluation, adjustment, and delivery of adaptive cardiac therapy. The systems, methods, and devices may utilize electrical heterogeneity information to determine and/or select one or more pacing settings and pacing type or configurations for a plurality of different heart rates. The adaptive cardiac therapy may deliver cardiac therapy at selected pacing settings such as, for example, A-V and/or V-V intervals, according to a presently measured heart rate and switch between left ventricular-only or biventricular cardiac pacing therapy also according to the presently measured heart rate.

    PATIENT SCREENING AND ECG BELT FOR BRADY THERAPY TUNING
    47.
    发明申请
    PATIENT SCREENING AND ECG BELT FOR BRADY THERAPY TUNING 有权

    公开(公告)号：US20220031221A1

    公开(公告)日：2022-02-03

    申请号：US17368260

    申请日：2021-07-06

    Applicant: Medtronic, Inc.

    Inventor： Ruth N. Klepfer ,  Manfred Justen ,  Subham Ghosh ,  Jeffrey M. Gillberg

    IPC: A61B5/35 ,  A61B5/28 ,  A61B5/00

    Abstract: Cardiac electrical activity is monitored from tissue of the patient using the plurality of external electrodes. One or more cardiac metrics of the patient are generated based on the monitored electrical activity. It is determined whether the patient is a candidate for a cardiac resynchronization therapy (CRT) device based on a first global dyssynchrony metric using the one or more cardiac metrics if the patient has a right bundle branch block. It is determined whether the patient is a candidate for a cardiac resynchronization therapy (CRT) device based on a second global dyssynchrony metric using the one or more cardiac metrics if the patient does not have a right bundle branch block.

    VFA cardiac therapy for tachycardia
    50.
    发明授权
    VFA cardiac therapy for tachycardia 有权

    公开(公告)号：US11058880B2

    公开(公告)日：2021-07-13

    申请号：US16362015

    申请日：2019-03-22

    Applicant: Medtronic, Inc.

    Inventor： Zhongping Yang ,  Subham Ghosh

    IPC: A61N1/36 ,  A61N1/362 ,  A61N1/05 ,  A61N1/365 ,  A61N1/375 ,  A61N1/39 ,  A61B5/287 ,  A61B5/366

    Abstract: VfA cardiac therapy uses an implantable medical device or system. The implantable medical device includes a tissue-piercing electrode implanted in the basal and/or septal region of the left ventricular myocardium of the patient's heart from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body. The device may include a right atrial electrode, a right atrial motion detector, or both. The device may be implanted completely within the patient's heart or may use one or more leads to implant electrodes in the patient's heart. The device may be used to provide cardiac therapy, including single or multiple chamber pacing, atrioventricular synchronous pacing, asynchronous pacing, triggered pacing, cardiac resynchronization pacing, or tachycardia-related therapy. A separate medical device may be used to provide some functionality for cardiac therapy, such as sensing, pacing, or shock therapy.

Patent Agency Ranking